Proteomics

Dataset Information

0

MYC as a Key Regulator of Protein Synthesis: Characterization of Downstream Targets in Multiple Myeloma


ABSTRACT: Multiple myeloma (MM) is a malignant plasma cell disorder and frequently characterized by the 16 dysregulation of the MYC oncogene, which is associated with poor prognosis and disease progression. While MYC's involvement in transcriptional regulation is well-established, the functional role of MYC target proteins and the impact on post-transcriptional processes in MM cells remain poorly understood. This study employed Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) coupled with mass spectrometry analysis to investigate the effects of MYC depletion on the proteome of MM cells. The results revealed that MYC primarily regulates translational processes. Specifically, the three RNA-binding proteins (RBPs) 4EBP1, hnRNPC, and LARP1, were prominently down-regulated upon MYC depletion in MM cells. Notably, high expression levels of these proteins were correlated with poor survival and disease progression in MM patients. These findings highlight the critical role of MYC in the regulation of translation and identify 4EBP1, hnRNPC, and LARP1 as MYC target proteins. Targeting these proteins may offer new therapeutic strategies and prognostic markers for MM, potentially improving patient outcomes. This study provides valuable insights into the post-transcriptional regulatory mechanisms mediated by MYC and opens avenues for further research in understanding and treating this devastating disease.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Frank Schnutgen  

PROVIDER: MSV000092169 | MassIVE | Thu Jun 15 02:19:00 BST 2023

REPOSITORIES: MassIVE

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1
altmetric image

Publications

The MYC-Regulated RNA-Binding Proteins hnRNPC and LARP1 Are Drivers of Multiple Myeloma Cell Growth and Disease Progression and Negatively Predict Patient Survival.

Seibert Marcel M   Koschade Sebastian E SE   Stolp Verena V   Häupl Björn B   Wempe Frank F   Serve Hubert H   Kurrle Nina N   Schnütgen Frank F   von Metzler Ivana I  

Cancers 20231121 23


Multiple myeloma (MM) is a malignant plasma cell disorder in which the MYC oncogene is frequently dysregulated. Due to its central role, MYC has been proposed as a drug target; however, the development of a clinically applicable molecule modulating MYC activity remains an unmet challenge. Consequently, an alternative is the development of therapeutic options targeting proteins located downstream of MYC. Therefore, we aimed to identify undescribed MYC-target proteins in MM cells using Stable Isot  ...[more]

Similar Datasets

2022-04-01 | GSE129279 | GEO
2017-05-01 | GSE94827 | GEO
2022-08-19 | GSE211342 | GEO
2022-03-28 | GSE163316 | GEO
2022-03-28 | GSE163145 | GEO
2022-03-28 | GSE163143 | GEO
2022-10-12 | PXD027480 | Pride
2021-03-22 | GSE148047 | GEO
2021-03-22 | GSE148046 | GEO
2021-03-22 | GSE148048 | GEO